Veru Inc Price/Sales
What is the Price/Sales of Veru Inc?
The Price/Sales of Veru Inc is 29.92
What is the definition of Price/Sales?
Price to sales ratio is a company’s stock price compared to its revenues.
ttm (trailing twelve months)
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales of companies in the Health Care sector on NASDAQ compared to Veru Inc
What does Veru Inc do?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
Companies with price/sales similar to Veru Inc
- Equatorial Palm Oil plc has Price/Sales of 29.78
- Sprott Focus Trust Inc has Price/Sales of 29.78
- BlackRock Enhanced Global Dividend Trust has Price/Sales of 29.79
- Globally Local Technologies has Price/Sales of 29.81
- Summit Therapeutics plc has Price/Sales of 29.87
- Sipa Resources has Price/Sales of 29.90
- Veru Inc has Price/Sales of 29.92
- Avalon GloboCare has Price/Sales of 29.97
- Amesite has Price/Sales of 30.00
- Else Nutrition has Price/Sales of 30.00
- Abivax SA has Price/Sales of 30.12
- Hazer has Price/Sales of 30.17
- Charter Hall Stapled Securities has Price/Sales of 30.20